STOCK TITAN

OSR Health awards CFO Gihyoun Bang 440,137 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

OSR Health, Inc. Chief Financial Officer Gihyoun Bang received an award of 440,137 shares of common stock on October 29, 2026. The shares are issuable under the 2025 Omnibus Incentive Plan in settlement of accrued unpaid salary. The award price was $0.2272 per share, equal to 115% of the volume-weighted average price for the 15 trading days ended October 28, 2026. The shares are subject to a six-month contractual lock-up; reported direct holdings after the award were 440,137 shares.

Insider Bang Gihyoun
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award OSRH F1 440,137 $0.2272 $100K
Holdings After Transaction: OSRH — 440,137 shares (Direct)
Holdings Before and After: OSRH, 0 to 440,137 shares (Direct)
Footnotes (1)
  1. F1. Represents shares of Common Stock issuable under the OSR Health, Inc. 2025 Omnibus Incentive Plan in settlement of accrued unpaid salary, at a price per share of $0.2272, equal to 115% of the volume-weighted average price of the Common Stock for the 15 trading days ended October 28, 2026. The award was approved by the Issuer's Board of Directors and Compensation Committee and is exempt under Rule 16b-3(d). The shares are subject to a six-month contractual lock-up from the grant date.
Award shares 440,137 shares Award to Chief Financial Officer Gihyoun Bang on October 29, 2026
Award price per share $0.2272 per share Price stated for the award
Award price relative to volume-weighted average price 115% Volume-weighted average price for the 15 trading days ended October 28, 2026
Reference period 15 trading days Period used for the volume-weighted average price ended October 28, 2026
Contractual lock-up Six months Applies to the awarded shares from the grant date
Direct holdings after award 440,137 shares Reported position following the October 29, 2026 award
2025 Omnibus Incentive Plan technical
"shares of Common Stock issuable under the OSR Health, Inc. 2025 Omnibus Incentive Plan"
An omnibus incentive plan is a company-wide program that authorizes awards of pay tied to performance and retention—such as stock options, restricted shares, cash bonuses and other rewards—here labeled for the year it was adopted (2025). Investors care because it affects how much ownership can be issued, dilutes existing shareholders, and aligns executives’ and employees’ incentives with company goals, similar to giving team members a stake in the outcome.
volume-weighted average price financial
"equal to 115% of the volume-weighted average price of the Common Stock"
Volume-weighted average price (VWAP) is the average price of a stock over a specific time period where each trade is weighted by the number of shares traded, so larger trades influence the average more than small ones. Investors and traders use VWAP as a reference point to judge whether trades are happening at relatively good or poor prices—like checking the average price paid for an item at a market where bulk purchases count more than single-item buys.
Rule 16b-3(d) regulatory
"The award ... is exempt under Rule 16b-3(d)"
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
contractual lock-up financial
"The shares are subject to a six-month contractual lock-up"
A contractual lock-up is an agreement that prevents certain shareholders from selling or transferring their shares for a specified period after a corporate event, such as an initial public offering or a merger. It matters to investors because it temporarily limits how many shares can come onto the market—think of it as a timed lockbox—and when the restriction ends there can be added selling pressure that may affect the stock's supply and price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did OSRH CFO Gihyoun Bang receive?

OSR Health Chief Financial Officer Gihyoun Bang received an award of 440,137 shares on October 29, 2026, in settlement of accrued unpaid salary.

What price was used for the OSRH share award?

The award price was $0.2272 per share, equal to 115% of the volume-weighted average price of common stock for the 15 trading days ended October 28, 2026.

What lock-up applies to the OSRH share award?

The shares are subject to a six-month contractual lock-up from the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bang Gihyoun

(Last)(First)(Middle)
10900 NE 4TH STREET, SUITE 2300

(Street)
BELLEVUE WASHINGTON 98004

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
OSR Health, Inc. [ OSRH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
OSRH10/29/2026A440,137A$0.2272(1)440,137D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares of Common Stock issuable under the OSR Health, Inc. 2025 Omnibus Incentive Plan in settlement of accrued unpaid salary, at a price per share of $0.2272, equal to 115% of the volume-weighted average price of the Common Stock for the 15 trading days ended October 28, 2026. The award was approved by the Issuer's Board of Directors and Compensation Committee and is exempt under Rule 16b-3(d). The shares are subject to a six-month contractual lock-up from the grant date.
/s/ Gihyoun Bang11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading